Read + Share
Sharp LN, Mirshahi UL, Colclough K, Hall TS, et al. MODY Is Prevalent in Later-Onset Diabetes and Has Potential for Targeted Therapy
but Is Challenging to Identify. Diabetes 2025 Nov 25:db250545. doi: 10.2337/db25-0545.
PMID: 41288518
|
 |
|
Sharp LN, Mirshahi UL, Colclough K, Hall TS, et al. MODY Is Prevalent in Later-Onset Diabetes and Has Potential for Targeted Therapy
but Is Challenging to Identify. Diabetes 2025 Nov 25:db250545. doi: 10.2337/db25-0545.
PMID: 41288518
|
|
|
|